Trial Profile
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Assess the Efficacy and Safety of 0.3% and 1% OPA-15406 Ointments in Patients With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2020
Price :
$35
*
At a glance
- Drugs Difamilast (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 14 Jul 2017 Status changed from recruiting to completed.
- 27 Sep 2016 New trial record